Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with few therapeutic options. While several gene mutations have been implicated in ALS, the exact cause of neuronal dysfunction is unknown and motor neurons of affected individuals display numerous cellular abnormalities. Ongo...
Main Authors: | Allison S. Limpert, Margrith E. Mattmann, Nicholas D. P. Cosford |
---|---|
Format: | Article |
Language: | English |
Published: |
Beilstein-Institut
2013-04-01
|
Series: | Beilstein Journal of Organic Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.3762/bjoc.9.82 |
Similar Items
-
Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
by: Eiichi Tokuda, et al.
Published: (2019-11-01) -
Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations
by: Eiichi Tokuda, et al.
Published: (2016-04-01) -
Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
by: Yoshiaki Furukawa, et al.
Published: (2020-08-01) -
Investigation of some variations of superoxide dismutase gene family in Turkish sporadic amyotrophic lateral sclerosis patients
by: Melda Büyüköz, et al.
Published: (2021-09-01) -
ZnII(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism
by: Erin J. McAllum, et al.
Published: (2015-09-01)